Hao Pan's Transactions at Orion Corporation
Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.
Managers' Transactions Overview
Person subject to the notification requirement
Name: Hao Pan
Position: Other senior manager
Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Notification type: INITIAL NOTIFICATION
Reference number: 74512/4/4
Transaction Details
Transaction date: Date of transaction
Venue: XLOM
Instrument type: SHARE
ISIN: FI0009014377
Nature of transaction: DISPOSAL
Transaction Breakdown
Volume: 1488
Unit price: 46.15 EUR
Aggregated transactions:
Volume: 1488
Volume weighted average price: 46.15 EUR
About Orion Corporation
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases, and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.
Frequently Asked Questions
What is the purpose of the Market Abuse Regulation?
The Market Abuse Regulation aims to ensure market integrity and investor protection by preventing and penalizing market abuse.
Who is Hao Pan?
Hao Pan is a senior manager at Orion Corporation, involved in significant transactions related to the company’s shares.
What type of transaction did Hao Pan conduct?
Hao Pan conducted a share disposal transaction, meaning he sold shares of Orion Corporation.
What is Orion Corporation's core focus?
Orion Corporation's core focus includes developing and marketing pharmaceuticals, particularly in oncology and pain management.
Where can I find more information about Orion Corporation?
Further information about Orion Corporation can be found on their official website and through their communication channels.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/